Literature DB >> 34558075

Increasing severity of early-onset atopic dermatitis, but not late-onset, associates with development of aeroallergen sensitization and allergic rhinitis in childhood.

Ann-Marie Malby Schoos1,2, Bo Lund Chawes1, Klaus Bønnelykke1, Jakob Stokholm1,2, Morten Arendt Rasmussen1, Hans Bisgaard1.   

Abstract

BACKGROUND: Early exposure to allergens through a defect skin barrier has been proposed as a mechanism for inducing sensitization and development of allergic diseases. We hypothesized that early-onset, severe atopic dermatitis (AD) is associated with development of aeroallergen sensitization and allergic rhinitis.
METHODS: We included 368 children from the Copenhagen Prospective Studies on Asthma in Childhood2000 (COPSAC2000 ) at-risk mother-child cohort. AD was diagnosed prospectively based on Hanifin&Rajka's criteria and severity assessed using the Scoring Atopic Dermatitis (SCORAD) index. Early-onset AD was defined as debut ≤1 year, late-onset as debut from 1-6 years. Aeroallergen sensitization and allergic rhinitis were diagnosed at ages 6-7 and 12 years. Associations between early-onset and late-onset AD and allergy endpoints were calculated using general estimating equations (GEE) models to compute the overall odds ratios (OR) for both time points.
RESULTS: Early-onset AD (yes/no) and severity (SCORAD) were associated with development of aeroallergen sensitization during childhood; GEE OR = 1.68 [1.08; 2.62], p = .02 and 1.08 [1.03; 1.12], p < .001, whereas late-onset AD showed a borderline significant association and late-onset severity showed no association; GEE OR = 1.65 [0.92; 2.94], p = .08 and 1.01 [0.97; 1.06], p = .55. The same trend was seen for allergic rhinitis with significant association between early-onset AD and allergic rhinitis; GEE OR = 1.56 [1.01; 2.41], p = .04 and severity; GEE OR = 1.09 [1.05; 1.13], p < .001, whereas late-onset AD showed no association. The effects on sensitization and rhinitis of early-onset versus late-onset AD severity were significantly different: p-interactionsensitization  = .03 and p-interactionrhinitis  < .01.
CONCLUSION: Increasing severity of early-onset AD, but not late-onset AD, associates with aeroallergen sensitization and allergic rhinitis later in childhood. ©2021 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Entities:  

Keywords:  allergic rhinitis; atopic dermatitis; early-onset; late-onset; specific IgE

Mesh:

Substances:

Year:  2021        PMID: 34558075     DOI: 10.1111/all.15108

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

1.  Vitamin D, skin filaggrin, allergic sensitization, and race.

Authors:  Elisabet Johansson; Jocelyn M Biagini; Lisa J Martin; Hua He; John W Kroner; Cassandra Almasri; Veronica Velasquez; Maud Sonzogni; Stanley B DeVore; Daniel Spagna; Brittany Grashel; Gurjit K Khurana Hershey
Journal:  Ann Allergy Asthma Immunol       Date:  2022-01-23       Impact factor: 6.248

2.  Clinical Characteristics of Atopic Dermatitis in Korean School-Aged Children and Adolescents According to Onset Age and Severity.

Authors:  You Hoon Jeon; Kangmo Ahn; Jihyun Kim; Meeyong Shin; Soo-Jong Hong; So-Yeon Lee; Bok Yang Pyun; Taek Ki Min; Minyoung Jung; Jeongmin Lee; Tae Won Song; Hye-Young Kim; Sooyoung Lee; Kyunguk Jeong; Yoonha Hwang; Minji Kim; Yong Ju Lee; Min Jung Kim; Ji Young Lee; Hye Yung Yum; Gwang Cheon Jang; Young A Park; Jeong Hee Kim
Journal:  J Korean Med Sci       Date:  2022-01-24       Impact factor: 2.153

3.  Food allergy testing in atopic dermatitis.

Authors:  Hassiel A Ramírez-Marín; Anne Marie Singh; Peck Y Ong; Jonathan I Silverberg
Journal:  JAAD Int       Date:  2022-08-18

4.  Atopic Dermatitis With Coexisting Food Allergy in Early Life Is Associated With Childhood Asthma.

Authors:  Sungsu Jung; So-Yeon Lee; Jisun Yoon; Hyun-Ju Cho; Min Jee Park; Kun Baek Song; Eom Ji Choi; Eun Young Paek; Song-I Yang; Eun Lee; Soo-Jong Hong
Journal:  Allergy Asthma Immunol Res       Date:  2022-09       Impact factor: 5.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.